Evidence map›Paper›PMID 39509915›Full record

ArticleClinics (Sao Paulo, Brazil)2024

A critical evaluation of the status of HPV vaccination in São Paulo State, Brazil.

Toni Ricardo Martins, Steven S Witkin, Andressa da Silva Ferreira, Juliana Yukari K Viscondi, Maryana Stephany Ferreira Branquinho, Lise Cury, Lucy Santos Vilas Boas, Adhemar Longatto-Filho, Maria Cássia Mendes-Corrêa

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinics (Sao Paulo, Brazil), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Toni Ricardo MartinsFaculdade de Ciências Farmacêuticas da Universidade Federal do Amazonas, Manaus, AM, Brazil; Programa de Pós graduação em Imunologia Básica e aplicada - PPGIBA - Universidade Federal do Amazonas, Manaus, Brasil. Electronic address: toni.martins@ufam.edu.br.
Steven S WitkinDepartment of Obstetrics and Gynecology, Weill Cornel Medicine, New York, USA; Medicine Tropical Institute, Virology Laboratory ‒ LIM/52, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil.
Andressa da Silva FerreiraUndergraduate Biomedicine Course at Universidade Paulista, São Paulo, SP, Brazil.
Juliana Yukari K ViscondiHealth Technology Assessment Unit, Oswaldo Cruz German Hospital (HAOC), São Paulo, SP, Brazil.
Maryana Stephany Ferreira BranquinhoBiomedicine Course at Universidade Paulista, São Paulo, SP, Brazil.
Lise CuryFundação Oncocentro de São Paulo (FOSP), São Paulo, SP, Brazil.
Lucy Santos Vilas BoasMedicine Tropical Institute, Virology Laboratory ‒ LIM/52, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil.
Adhemar Longatto-FilhoLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal; Medical Laboratory of Medical Investigation (LIM) 14, Department of Pathology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil; Molecular Oncology Research Center, Hospital de Câncer de Barretos, São Paulo, SP, Brazil.
Maria Cássia Mendes-CorrêaMedicine Tropical Institute, Virology Laboratory ‒ LIM/52, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil; Infectious Diseases Department, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cervical cancer, whose well-recognized etiological agent is the Human Papillomavirus (HPV), is responsible for approximately 300,000 deaths worldwide, 80% of cases occurring in developing countries. In Brazil, 17,010 cases were expected, with 2,550 cases in São Paulo State, in 2023. The Papanicolaou test is the diagnostic method for the detection of precancerous lesions of the cervix, and HPV vaccination is now available for prevention. MATERIALS AND

methodsThis is a descriptive and exploratory, retrospective investigation, carried out through analysis of data obtained from Brazilian Information Technology (DATASUS) of the Brazilian Federal Government: Cancer Information System (SISCAN), Brazilian National Immunization Program (PNI) and Mortality Information System (SIM). Electronic Library and data made available by the Government of the State of São Paulo.

resultsThe number of women in São Paulo State who underwent cytological examinations and histological tests for cervical cancer decreased between the Years 2013 and 2022.

conclusionThe continuous increase in cervical cancer over the study period was probably due to the lack of adherence to the primary and secondary prevention opportunities offered by the Public Health Authorities.

Indexed as

Papillomavirus InfectionsPapillomavirus VaccinesUterine Cervical NeoplasmsAdolescentAdultBrazilFemaleHumansMiddle AgedPapanicolaou TestRetrospective StudiesVaccinationVaginal SmearsYoung AdultPapillomavirus VaccinesCervical CancerHPVHPV vaccinePapanicolaou Test

Identifiers

PMID39509915
PMCPMC11570814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.